
Sign up to save your podcasts
Or
Are you aware of the rapid progress for patients with epidermal growth factor receptor (EGFR) exon 20 insertion-mutated non-small cell lung cancer (NSCLC) and strategies for tackling osimertinib resistance? Credit available for this activity expires: [07/11/23] Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/976634?src=mkm_podcast_addon_976634
4
77 ratings
Are you aware of the rapid progress for patients with epidermal growth factor receptor (EGFR) exon 20 insertion-mutated non-small cell lung cancer (NSCLC) and strategies for tackling osimertinib resistance? Credit available for this activity expires: [07/11/23] Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/976634?src=mkm_podcast_addon_976634
131 Listeners
13 Listeners
323 Listeners
866 Listeners
492 Listeners
695 Listeners
18 Listeners
276 Listeners
252 Listeners
3,318 Listeners
258 Listeners
87 Listeners
1,087 Listeners
186 Listeners
514 Listeners
348 Listeners
59 Listeners
25 Listeners
286 Listeners